Abstract
Background: Lipid abnormalities in albuminuria in patients with Type 2 diabetes differ by race. Aim: To perform a biochemical investigation of association between dyslipidemia and albuminuria in Type 2 diabetes in Taiwan. Materials/subjects and methods: We recruited a total of 2349 Chinese patients with Type 2 diabetes from two medical centers in Taiwan over a 1-yr period. Patients were categorized into those with normoalbuminuria, microalbuminuria, and macro-albuminuria defined as albumin-to-creatinine ratio of <30, 30–299, and ≥300 µg/mg. We then investigated the significance of the clinical and biochemical parameters and risk of albuminuria. Results: We found significant differences in total cholesterol (TC) between those with normoalbuminuria and micro/macroalbuminuria, no significant difference in LDL cholesterol (LDL-C) among the 3 subgroups, a significant difference in HDL cholesterol (HDL-C) between those with normoalbuminuria and macroalbuminuria, and significant increases in triglyceride (TG) paralleling increases in albuminuria. TG was found by logistic regression to be significantly associated with micro/macroalbuminuria in our unadjusted model [odds ratio (OR) = 1.859 (1.596∼2.165)], and remained significant after adjusting for various confounders [OR = 1.415 (1.123∼1.784)]. Increases in albuminuria paralleled quartile increases in serum TG (p<0.001). Conclusions: We conclude that TG increases significantly throughout the 3 stages of albuminuria in Taiwanese Type 2 diabetic patients, but TC, HDL-C, and LDL-C do not.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Atkins RC. The epidemiology of chronic kidney disease. Kidney Int Suppl 2005, 94: S14–8.
Dinneen SF, Gerstein HC. TThe association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997, 157: 1413–8.
Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982, 1: 1430–2.
Parving HH, Oxenbøll B, Svendsen PA, Christiansen JS, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 1982, 100: 550–5.
Bonnet F, Cooper ME. Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies. Diabetes Metab 2000, 26: 254–64.
Wilens SL, Elster SK, Baker JP. Glomerular lipidosis in intercapillary glomerulosclerosis. Ann Intern Med 1951, 34: 592–607.
American Diabetes Association. Standards of medical care in diabetes—2007. Diabetes care 2007, 30(Suppl 1): S4–41.
Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR; UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006, 55: 1832–9.
Hashim R, Khalil-ur-Rehman, Ahmed TA, Mushtaq S, Zafar L, Attique M. Microalbumiuria and associated risk factors in type II diabetics. J Coll Physicians Surg Pak 2004, 14: 84–7.
Seghieri G, Alviggi L, Caselli P, et al. Serum lipids and lipoproteins in type 2 diabetic patients with persistent microalbuminuria. Diabet Med 1990, 7: 810–4.
Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG; DEMAND investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006, 69: 2057–63.
Kim DM, Ahn CW, Park JS, et al. An implication of hypertriglyceridemia in the progression of diabetic nephropathy in metabolically obese, normal weight patients with type 2 diabetes mellitus in Korea. Diabetes Res Clin Pract 2004, 66(Suppl 1): S169–72.
Nelson RG, Knowler WC, Pettitt DJ, Hanson RL, Bennett PH. Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM. Diabetes Care 1995, 18: 182–7.
Gall MA, Hougaard P, Borch-Johnsen K, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 1997, 314: 783–8.
Bruno G, Merletti F, Biggeri A, et al; Casale Monferrato Study. Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 2003, 26: 2150–5.
Oue T, Namba M, Nakajima H, et al. Risk factors for the progression of microalbuminuria in Japanese type 2 diabetic patients—a 10 year follow-up study. Diabetes Res Clin Pract 1999, 46: 47–55.
Tseng CH. Lipid abnormalities associated with urinary albumin excretion rate in Taiwanese type 2 diabetic patients. Kidney Int 2005, 67: 1547–53.
Ma Y, Li Y, Chiriboga DE, et al. Association between carbohydrate intake and serum lipids. J Am Coll Nutr 2006, 25: 155–63.
Hypertriglyceridaemia and vascular risk. Report of a meeting of physicians and scientists, University College London Medical School. Lancet 1993, 342: 781–7.
Fay WP. Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury. Trends Cardiovasc Med 2004, 14: 196–202.
Fogo AB. Renal fibrosis: not just PAI-1 in the sky. J Clin Invest 2003, 112: 326–8.
Kamgar M, Nobakhthaghighi N, Shamshirsaz AA, Estacio RO, McFann KK, Schrier RW. Impaired fibrinolytic activity in type II diabetes: correlation with urinary albumin excretion and progression of renal disease. Kidney Int 2006, 69: 1899–903.
McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PW, Schaefer EJ. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis 1987, 7: 483–90.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tien, KJ., Tu, ST., Chen, HC. et al. Triglycerides are independently associated with albuminuria in Taiwanese Type 2 diabetic patients. J Endocrinol Invest 35, 800–803 (2012). https://doi.org/10.3275/8060
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3275/8060